Medisys Opens Production Facility for Medical Devices in Israel.Business Editors BATON ROUGE Baton Rouge (băt`ən r  zh) [Fr.,=red stick], city (1990 pop. 219,531), state capital and seat of East Baton Rouge parish, SE La. , La. & FAR HILLS, N.J.--(BW HealthWire)--July 31, 2000 Medisys Technologies, Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: SCEP SCEP Student Career Experience Program SCEP Simple Certificate Enrollment Protocol (Cisco) SCEP Syndicat Canadien des Communications, de l'Énergie et du Papier (Communications, Energy and Paperworkers Union) ), a pioneer in the design and development of safety needle devices, today announced the grand opening of the production facility of Medisys' safety devices in Dimona, Israel on June 28, 2000. Medisys president, Kerry Frey, attended a grand opening ceremony hosted at Dispomedic 2000 in Dimona, Israel. Dignitaries from the Israeli government and local civic leaders participated in the formal dedication of Dispomedic 2000, an Israeli manufacturer, for the production of CoverTip(TM) syringes. Medisys patented CoverTip hypodermic syringe hypodermic syringe n. A syringe with a calibrated barrel, plunger, and tip, used with a hypodermic needle for hypodermic injections and for aspiration. , has now entered the market to replace conventional devices in protecting healthcare workers against accidental needlesticks and sharps injuries. A tour of the plant was conducted where manufacturing equipment was observed in full operation producing CoverTip syringes. Medisys president Kerry Frey said, "The facility and the people at Dispomedic exceeded our expectations. The highly motivated and skillfull professionals in the Dimona operation are a pleasure to work with. Our agreement with Dispomedic will allow for the CoverTip to enter a market thirsty for practical and affordable safety syringes. " In January 2000, Medisys entered into a multi-phase, proprietary agreement with Dispomedic 2000. About Medisys Technologies, Inc. Medisys Technologies, Inc. has 19 U.S. patents covering medical safety devices and other products. In addition to the CoverTip(TM) hypodermic syringe, the Medisys portfolio of patented safety devices includes: BXDraw(TM), a fine needle biopsy/aspiration safety syringe; SofDraw(TM), a blood and fluid collection safety syringe; and MultiDraw(TM), a needleless multiple vacuum vial vial a small bottle. blood collection safety device. The Company has filed, or is filing, patent applications for new safety designs in blood collection, capillary capillary (kăp`əlĕr'ē), microscopic blood vessel, smallest unit of the circulatory system. Capillaries form a network of tiny tubes throughout the body, connecting arterioles (smallest arteries) and venules (smallest veins). blood testing, and tissue excision cutting needles. In total, the Company has 19 patent applications pending for its medical devices both in the U.S. and overseas. Statements in this release may be construed to be forward looking and are made pursuant to the Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Reform Act of 1995. Investors are cautioned that all forward-looking statement forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. involve risks and uncertainties, including, but not limited to, risks associated with regulatory approvals, lack of adequate capitalization and/or other risks inherent in medical device and other product development. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion